A vascular interventional medical device, system and application thereof
By incorporating electrical signal transmission components and electromagnetic shielding devices into vascular interventional medical devices, the problem of external electromagnetic signal interference is solved, thereby improving the accuracy and stability of signal transmission.
Patent Information
- Application Number
- CN202311030720.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-08-15
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2043-08-15
AI Technical Summary
Existing vascular interventional medical devices are easily affected by external electromagnetic interference when transmitting signals within blood vessels, which affects the accuracy of signal transmission.
An electrical signal transmission component is mounted on the flexible main frame of the vascular interventional medical device, and an electromagnetic shield is provided to reduce interference from external electromagnetic signals. This includes the electrical signal transmission component of the electrodes and wires, and the configuration of the electromagnetic shield to block external electromagnetic signal interference.
It improves the accuracy of electrical signal transmission in vascular interventional medical devices, reduces interference from external electromagnetic signals, and ensures the stability and reliability of signal transmission.
Smart Images

Figure CN117158916B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of medical devices, and in particular to a vascular interventional medical device, system and application thereof. Background Art
[0002] Each organ of the human body is supplied with blood by arteries, which provide oxygen and nutrients to the tissues, and then return to the heart (atrium) through veins. If arterial stenosis reaches a certain degree due to various reasons, tissue and organ ischemia and hypoxia may occur, and even tissue reconstruction, damage, and necrosis may occur, resulting in ischemic diseases of various organs (such as coronary heart disease caused by coronary artery ischemia). In recent years, with the improvement of technology, methods, hardware and software, and equipment, vascular interventional diagnosis and treatment has become an important means in the medical field. It includes interventional diagnosis and treatment of coronary heart disease, interventional diagnosis and treatment of renal arteries, interventional diagnosis and treatment of carotid arteries, interventional diagnosis and treatment of aorta, and interventional diagnosis and treatment of upper and lower limb arteries. Existing vascular interventional medical devices generally include an internal stent, and an electrode sheet is fixed on the internal stent, and then a thin wire is connected to the electrode sheet by resistance welding, and is led to a telemetry circuit, thereby realizing the transmission of electrical signals between the blood vessel and the external circuit to realize the detection of relevant health information. However, since the interventional medical device needs to intervene in the blood vessel, its size is small, and the transmitted electrical signal is generally weak, which is easily interfered by external electromagnetic signals, thereby affecting the accuracy of its signal transmission. Summary of the invention
[0003] The present invention aims to solve at least one of the technical problems existing in the prior art. To this end, the present invention provides a vascular intervention medical device, system and application thereof.
[0004] In a first aspect of the present invention, a vascular interventional medical device is provided, comprising:
[0005] A main frame, wherein the main frame is an elastic support frame;
[0006] An electrical signal transmission component, the electrical signal transmission component is arranged on the main frame, and comprises an electrode and a wire, wherein the wire is electrically connected to the electrode;
[0007] An electromagnetic shielding component is configured to reduce or block interference of external electromagnetic signals on the electrical signal transmitted by the electrical signal transmission component.
[0008] According to the embodiment of the present invention, the vascular interventional medical device has at least the following beneficial effects: the vascular interventional medical device is further configured with an electromagnetic shielding component on the basis of an electrical signal transmission component including electrodes and wires arranged on an elastic main frame, so as to reduce or block the interference of external electromagnetic signals on the electrical signals transmitted by the electrical signal transmission component through the electromagnetic shielding component, thereby improving the accuracy of electrical signal transmission of the vascular interventional medical device.
[0009] In some embodiments of the present invention, the electromagnetic shielding component is provided on at least one side of the electrical signal transmission component.
[0010] In some embodiments of the present invention, the electromagnetic shielding component is disposed on a side of the electrical signal transmission component away from the main frame, covering the wire and exposing at least a portion of the electrode.
[0011] In some embodiments of the present invention, the electromagnetic shielding component is disposed between the electrical signal transmission component and the main frame.
[0012] In some embodiments of the present invention, the electromagnetic shielding component is disposed between the electrical signal transmission component and the main frame, and on a side of the electrical signal transmission component away from the main frame, covering the wire and exposing at least part of the electrode.
[0013] In some embodiments of the present invention, the electromagnetic shielding member is disposed around the electrical signal transmission component and exposes at least a portion of the electrode.
[0014] In some embodiments of the present invention, an insulating layer is provided between the electromagnetic shielding component and the electrical signal transmission component.
[0015] In some embodiments of the present invention, the electromagnetic shielding component is any one of a metal shielding layer, a carbon nanotube shielding layer, a ferrite shielding layer, and a graphene shielding layer; preferably, the material of the metal shielding layer is selected from at least one of platinum and gold.
[0016] In some embodiments of the present invention, the material of the insulating layer is selected from at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
[0017] In some embodiments of the present invention, the electrical signal transmission component is configured by a conductive material layer.
[0018] In some embodiments of the present invention, the electrode and the wire are integrated into one structure.
[0019] In some embodiments of the present invention, the conductive material layer is a metal material layer, a non-metallic conductive material layer, or a composite layer of a non-metallic conductive material layer and a metal material layer.
[0020] In some embodiments of the present invention, the conductive material layer includes a non-precious metal conductive base layer and a precious metal protective layer, the non-precious metal conductive base layer is arranged on the surface of the main frame, and the precious metal protective layer covers the non-precious metal conductive base layer; the material of the precious metal protective layer is selected from at least one of platinum and gold.
[0021] In some embodiments of the present invention, the thickness of the conductive material layer is less than 5 μm.
[0022] In some embodiments of the present invention, the main frame is configured to be contractible and expandable along a central axis.
[0023] In some embodiments of the present invention, the main frame is in the shape of a hollow tube.
[0024] In some embodiments of the present invention, the side wall of the main frame is a mesh structure.
[0025] In some embodiments of the present invention, the electrodes are disposed at intersections of mesh structures on the main frame.
[0026] In some embodiments of the present invention, there are two or more electrodes.
[0027] In some embodiments of the present invention, the electrodes are evenly arranged along the radial direction and / or the axial direction of the main frame.
[0028] In some embodiments of the present invention, a modification layer is provided on the surface of the electrode, and the modification layer has a biological signal recognition function for identifying and detecting changes in biological signals within blood vessels, and converting the changes in the biological signals into readable electrical signals through the electrode and transmitting them to an external circuit; the biological signals include chemical signals and / or physical signals related to the physiological condition of the organism.
[0029] In some embodiments of the present invention, the material of the modification layer is selected from at least one of enzymes, redox mediators, nanomaterials, antibodies, biotin, nucleic acid aptamers, polymers, ion carriers, and piezoelectric materials.
[0030] In some embodiments of the present invention, the enzyme is selected from at least one of oxidoreductase, transferase, hydrolase, lyase, ligase and isomerase.
[0031] In some embodiments of the present invention, the oxidoreductase is selected from the group consisting of glucose oxidase, glutamate oxidase, alcohol oxidase, lactate oxidase, amino acid oxidase, cholesterol oxidase, choline oxidase, nicotinamide adenine dinucleotide phosphate oxidase, oxalate oxidase, cytochrome oxidase, bilirubin oxidase, serotoninase, galactose oxidase, glucose dehydrogenase, lactate dehydrogenase, alcohol dehydrogenase, aldehyde dehydrogenase, glutamate dehydrogenase, pyruvate dehydrogenase, sorbitol dehydrogenase, formate dehydrogenase, cellobiose dehydrogenase, amino acid dehydrogenase, succinate dehydrogenase, catalase, horseradish peroxidase, lactoperoxidase, glutathione At least one of peptide peroxidase, ascorbate peroxidase, soybean peroxidase, cytochrome peroxidase, thyroid peroxidase, myeloperoxidase, superoxide dismutase, haloperoxidase, thiol peroxidase, 5α reductase, 5β reductase, aldehyde reductase, aldose reductase, hydroxymethylglutaryl CoA reductase, methemoglobin reductase, ribonucleotide reductase, nitroreductase, thioredoxin reductase, dihydrofolate reductase, disulfide reductase, sulfite reductase, cytochrome reductase, imine reductase, fumarate reductase, carboxylic acid reductase, and dimethyl sulfoxide reductase.
[0032] In some embodiments of the present invention, the transferase is selected from at least one of glutathione transferase, acetyltransferase, methyltransferase, transketolase, transaldolase, glycosyltransferase, transketolase, amino acid transferase, and acyltransferase.
[0033] In some embodiments of the present invention, the hydrolase is selected from at least one of lipase, phosphohydrolase, glycoside hydrolase, acetylhydrolase, nucleotide hydrolase, helicase, peptide hydrolase, urease and creatinine deiminase.
[0034] In some embodiments of the present invention, the lyase is selected from at least one of a decarboxylase, a dehydrogenase, a dehalogenase, an aspartate ammonia lyase, and a cysteine desulfurase.
[0035] In some embodiments of the present invention, the ligase is selected from at least one of tRNA synthetase, succinyl coenzyme A synthetase, amino acid ligase, DNA ligase, RNA ligase, and carboxylase.
[0036] In some embodiments of the present invention, the isomerase is selected from at least one of a racemase, an epimerase, and a mutase.
[0037] In some embodiments of the present invention, the nanomaterial is selected from at least one of metal nanomaterials, nanoceramics, nanoglass, and nanopolymer materials.
[0038] In some embodiments of the present invention, the antibody is selected from at least one of C-reactive protein antibody, thyrotropin antibody, bilirubin antibody, albumin antibody, carcinoembryonic antigen antibody, alpha-fetoprotein antibody, prostate-specific antigen antibody, cancer antigen 125 antibody, and cortisol antibody.
[0039] In some embodiments of the present invention, the nucleic acid aptamer is selected from at least one of a DNA type oligonucleotide chain and an RNA type oligonucleotide chain.
[0040] In some embodiments of the present invention, the polymer is selected from at least one of polyaniline, polypyrrole, polyacetylene, polycarbazole, polythiophene, polyphenylene methylene, poly(3,4-ethylenedioxythiophene), polystyrene sulfonic acid, chitin, chitosan, polyvinyl chloride, polyvinyl butyral, and Nafion.
[0041] In some embodiments of the present invention, the ion carrier is selected from at least one of potassium ion, sodium ion, calcium ion, magnesium ion, iron ion, zinc ion, manganese ion, copper ion, molybdenum ion, cobalt ion, cobalt ion, chromium ion, chloride ion, sulfate ion, and phosphate ion.
[0042] In some embodiments of the present invention, the piezoelectric material is selected from at least one of single crystal piezoelectric ceramics, polycrystalline piezoelectric ceramics, piezoelectric polymers, and polymer-piezoelectric ceramic composites.
[0043] In some embodiments of the present invention, the area on the main frame corresponding to the setting position of the electrical signal transmission component constitutes an electrical signal transmission component assembly part, and along the direction toward the center of the main frame, the outer contour size of the electrical signal transmission component assembly part is equal to or greater than the outer contour size of the corresponding area of the electromagnetic shielding component.
[0044] In some embodiments of the present invention, an electrical signal transmission component assembly groove is provided on the electrical signal transmission component assembly portion, and the electrical signal transmission component is assembled in the electrical signal transmission component assembly groove.
[0045] In some embodiments of the present invention, the material of the main frame is selected from degradable polymer materials; or, the material of the main frame is selected from at least one of shape memory alloys and iron, and a dielectric layer is provided on the surface of the main frame, and the dielectric layer is arranged toward the side of the electrical signal transmission component.
[0046] In some embodiments of the present invention, the material of the dielectric layer is selected from at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
[0047] In some embodiments of the present invention, the shape memory alloy is selected from at least one of Nitinol alloy, cobalt-chromium alloy and magnesium alloy.
[0048] In some embodiments of the present invention, the vascular interventional medical device further comprises an insulating packaging layer, which is arranged as the outermost layer on a side of the main frame where the electrical signal transmission component is provided, and exposes at least a portion of the electrode.
[0049] In some embodiments of the present invention, the material of the insulating packaging layer is selected from at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
[0050] In some embodiments of the present invention, the vascular interventional medical device further includes a buffer protection component, which is disposed at the implantation front end of the vascular interventional medical device and is configured to reduce the risk of puncturing a blood vessel during the implantation process of the vascular interventional medical device.
[0051] In some embodiments of the present invention, the vascular intervention medical device further includes a delivery component configured to deploy and implant the vascular intervention medical device into a blood vessel.
[0052] A second aspect of the present invention provides a vascular interventional medical system, comprising any vascular interventional medical device provided in the first aspect of the present invention.
[0053] The third aspect of the present invention proposes the use of any one or more vascular interventional medical devices in constructing an in vitro cultured cell construct, an electrical signal collection cell construct or an electrical stimulation cell construct. BRIEF DESCRIPTION OF THE DRAWINGS
[0054] The present invention will be further described below with reference to the accompanying drawings and embodiments, wherein:
[0055] Figure 1 It is a structural schematic diagram of an embodiment of a vascular interventional medical device of the present invention;
[0056] Figure 2 for Figure 1 The schematic diagram of the structure of the vascular interventional medical device after being deployed along the AA line on the side wall;
[0057] Figure 3 for Figure 2 A partial enlarged view of the middle M region;
[0058] Figure 4 for Figure 3 Enlarged cross-sectional view along line BB;
[0059] Figure 5 for Figure 4 A local magnified image of the middle N region;
[0060] Figure 6 for Figure 2 A schematic diagram of the structure of the main frame of the vascular interventional medical device after deployment is shown;
[0061] Figure 7 for Figure 2 A schematic diagram of the structure of the dielectric layer in the vascular interventional medical device after deployment;
[0062] Figure 8 for Figure 2 A schematic diagram of the structure of the first electromagnetic shielding component in the vascular interventional medical device after deployment;
[0063] Fig. 9 for Figure 2 A schematic diagram of the structure of the first insulating layer in the vascular interventional medical device after deployment is shown;
[0064] Fig.10 for Figure 2 A schematic diagram of the structure of the electrical signal transmission component in the vascular interventional medical device after deployment;
[0065] Fig.11 for Figure 2 A schematic diagram of the structure of the second insulating layer in the vascular interventional medical device after deployment;
[0066] Fig.12 for Figure 2 A schematic diagram of the structure of the second electromagnetic shielding component in the vascular interventional medical device after deployment;
[0067] Fig.13 for Figure 2 A schematic diagram of the structure of the insulating packaging layer in the vascular interventional medical device after deployment is shown. DETAILED DESCRIPTION
[0068] Embodiments of the present invention are described in detail below, examples of which are shown in the accompanying drawings, wherein the same or similar reference numerals throughout represent the same or similar elements or elements having the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.
[0069] In the description of the present invention, "several" means more than one, "many" means more than two, "greater than", "less than", "exceed", etc. are understood to exclude the number itself, and "above", "below", "within", etc. are understood to include the number itself. If there is a description of "first" or "second", it is only used for the purpose of distinguishing the technical features, and cannot be understood as indicating or implying the relative importance or implicitly indicating the number of the indicated technical features or implicitly indicating the order of the indicated technical features.
[0070] In the description of the present invention, unless otherwise clearly defined, terms such as setting, installing, connecting, etc. should be understood in a broad sense, and technicians in the relevant technical field can reasonably determine the specific meanings of the above terms in the present invention based on the specific content of the technical solution.
[0071] In the description of the present invention, the description with reference to the terms "one embodiment", "some embodiments", "illustrative embodiments", "examples", "specific examples", or "some examples" means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner.
[0072] See also Figures 1 to 5 and Fig.10 The vascular interventional medical device comprises a main frame 10, an electrical signal transmission component 20, an insulating packaging layer 30 and an electromagnetic shielding component 40. The main frame 10 is an elastic support frame; the electrical signal transmission component 20 is arranged on the main frame 10, and comprises an electrode 21 and a wire 22, and the wire 22 is electrically connected to the electrode 21; the insulating packaging layer 30 is arranged on the outermost layer of the main frame 10 on the side where the electrical signal transmission component 20 is arranged, and exposes at least part of the electrode 21; the electromagnetic shielding component 40 is arranged between the insulating packaging layer 30 and the main frame 10, and is configured to reduce or block the interference of external electromagnetic signals on the electrical signals transmitted by the electrical signal transmission component.
[0073] The vascular interventional medical device is mainly configured for vascular interventional diagnosis and treatment, and the main frame 10 is generally configured to be able to shrink and expand along the central axis, and can shrink and expand with the blood vessel in the blood vessel, so as to facilitate the implantation of the blood vessel and keep the device in contact with the inner wall of the blood vessel for stable support. Specifically, the main frame 10 can be designed to be a hollow tube, such as a hollow round tube, a hollow C-shaped tube, etc. Through the above tubular structure and elastic deformable design, the adaptability to the blood vessel, the compatibility and the detection accuracy can be improved. The diameter of the main frame 10 can be designed to be 1 to 10 mm, the length can be designed to be 10 to 100 mm, and the side wall thickness can be designed to be 10um to 1mm. In order to further reduce blood flow obstruction, improve the portability of the device structure and reduce the foreign matter and discomfort caused by the device intervention in the organism, the main frame 10 can be designed to have a mesh structure on the side wall; of course, in some embodiments, the side wall can also be designed with other hollow structure designs, or even without a hollow design. The main frame 10 of the mesh structure or other hollow structure can be formed by first setting a basic support layer, and then hollowing out the basic support layer by laser engraving or etching to form a mesh structure or other hollow structure; or the main frame 10 of the mesh structure can also be formed by weaving a plurality of main strips. Figures 1 to 6 In this embodiment, the main frame 10 is a hollow C-shaped tube with a mesh-like side wall.
[0074] In addition, the material of the main frame 10 can be selected as needed, and a deformable material with biocompatibility can be specifically selected. For example, a degradable polymer material can be used, or at least one of a shape memory alloy and iron can be used, wherein the shape memory alloy can specifically be selected from at least one of a nitinol alloy, a cobalt-chromium alloy, and a magnesium alloy. In addition, if the material of the main frame 10 is a conductive material (such as a shape memory alloy, iron, etc.), it is generally necessary to ensure that the main frame 10 is electrically isolated from other conductive components. Therefore, a dielectric layer 50 for achieving electrical insulation is usually provided between the main frame 10 and other conductive components; and if the material of the main frame 10 is an insulating material, such as an insulating degradable polymer material, the dielectric layer 50 can be eliminated. Among them, the material of the dielectric layer 50 can be selected from at least one of polyimide (PI), polydimethylsiloxane (PDMS), polyparaphenylene benzobisoxazole (PBO), and SU8. In this embodiment, the material of the main frame 10 is selected from Nitinol alloy, and the surface of the main frame 10 is provided with a dielectric layer 50 formed of polyimide, and the dielectric layer 50 is specifically provided on the surface of the main frame 10 on the side where the electrical signal transmission component 20 is provided. Figure 4 , Figure 5 and Figure 7 shown.
[0075] The electrical signal transmission component 20 can be configured as required. In some embodiments, the wire 22 and the electrode 21 can be arranged on the main frame 10 and connected by resistance welding to form the electrical signal transmission component 20, wherein the wire 22 and the electrode 21 can be arranged on the main frame 10 by bonding or other means. However, since the vascular interventional diagnosis and treatment device itself is relatively small in size, if the wire 22 is arranged on the mesh structure of the main frame 10, the size of the wire 22 is generally required to be thinner, and it is connected to the electrode 21 by resistance welding, and the connection stability is relatively poor. In this embodiment, the electrical signal transmission component 20 is configured with a conductive material layer, and the conductive material layer is configured to form the electrical signal transmission component 20 containing the electrode 21 and the wire 22, wherein the electrode 21 and the wire 22 are an integrated structure, such as Fig.10 As shown. In the preparation process, the corresponding conductive material configuration can be used to form a conductive material base layer, and then the electrode 21 and the wire 22 can be made by laser engraving or etching to form an electrical signal transmission component 20. The above electrical signal transmission component 20 containing the electrode 21 and the wire 22 is formed by configuring the conductive material layer, which can meet the requirements of thin wires. The width of the wire 22 can be controlled to be less than 100μm, or even less than 25μm, and even less than 10μm, such as 5μm, 8μm, etc., and the thickness can be controlled to be less than 5μm; and the electrode 21 and the wire 22 can be integrated into a structure, which is not easy to break even if it is subjected to blood flow erosion in the blood vessel for a long time, has strong stability, and has a simple structure.
[0076] The electrical signal transmission component 20 can be arranged inside or outside the main frame 10, and can be arranged specifically according to the detection needs. For example, if the target detection object of the vascular interventional diagnosis and treatment device is blood, the electrical signal transmission component 20 can be arranged inside the main frame 10; if the target detection or action object of the vascular interventional diagnosis and treatment device is blood vessels or vascular wall cells, such as the vascular interventional diagnosis and treatment device is used to electrically stimulate vascular wall cells, the electrical signal transmission component 20 can be arranged outside the main frame 10. Figure 1As shown, in this embodiment, the electrical signal group transmission component 20 is arranged on the outside of the main frame 10. The electrical signal transmission component 20 or the conductive material layer of the electrical signal transmission component 20 generally adopts a biocompatible conductive material, including a metal material and / or a non-metallic conductive material. For example, the conductive material layer of the electrical signal transmission component 20 can be a metal material layer, a non-metallic conductive material layer, or a composite layer of a non-metallic conductive material layer and a metal material layer. In addition, in order to ensure biocompatibility, the metal material layer generally adopts a precious metal material, such as platinum, gold, etc.; the non-metallic conductive material layer usually also adopts a biocompatible non-metallic conductive material, and the specific type is not limited; and if the conductive material layer of the electrical signal transmission component 20 adopts a composite form of a non-metallic conductive material layer and a metal material layer, and the metal material layer is covered on the outer layer of the non-metallic conductive material layer, when isolating and blocking the non-metallic conductive material layer, it is not even required that the non-metallic conductive material layer has biocompatibility, and only the outermost metal material layer needs to adopt a biocompatible metal material, such as platinum, gold, etc. In order to save costs or enhance conductivity, the conductive material layer constituting the electrical signal transmission component 20 can be designed to be composed of a non-precious metal conductive base layer and a precious metal protective layer covering the non-precious metal conductive base layer. The non-precious metal conductive base layer can be made of non-metallic conductive materials and / or non-precious metal-like metal materials, for example, a non-metallic conductive base layer or a non-precious metal-like metal conductive base layer; the material of the precious metal protective layer can be at least one of platinum and gold. The metal material layer can be made by at least one of sputtering, evaporation, and chemical vapor deposition. The metal material layer obtained by the above method has good uniformity and strong adhesion stability, which can improve the stability of the structure.
[0077] The number of electrodes 21 configured on the electrical signal transmission component 20 or the conductive material layer that constructs the electrical signal transmission component 20 can be designed to be one or more (such as 2, 3, 5, 8, 10, 15, 20, etc.), and can be set specifically according to actual needs, generally more than two, to achieve multi-point detection or action, improve detection accuracy or action uniformity; and, the electrodes 21 can be evenly arranged along the radial and / or axial direction of the hollow tubular main frame to further improve the detection accuracy or action uniformity, as well as improve the stability of the structure.
[0078] For the main frame 10 with a mesh-like sidewall, the electrodes 21 in the electrical signal transmission component 20 can be arranged at the intersection of the mesh-like structure on the main frame 10, thereby improving the stability of the electrodes 21. Figure 1 and Figure 2As shown, in this embodiment, the electrode 21 is arranged at the intersection of part of the mesh structure on the main frame 10. In some embodiments, the electrode 21 can also be arranged at all the intersections of the mesh structure on the main frame 10; of course, in some embodiments, the electrode 21 can be arranged not at the intersection of the mesh structure on the main frame 10, but between the two intersections. The shape of the electrode 21 can be designed according to the needs, and generally adopts a shape with a soft curvature, such as a circle, an ellipse, a semicircle, a ring, etc., to improve the safety of the structure in the human body; of course, in some embodiments, the electrode 21 can also adopt other shapes, such as a square, etc.
[0079] In addition, a modification layer may be provided on the surface of the electrode 21, and the modification layer may be specifically configured to have a biological signal recognition function, for identifying and detecting changes in biological signals in the blood vessels, and converting the changes in biological signals into readable electrical signals through the electrode 21 and transmitting them to the external circuit; biological signals include chemical signals and / or physical signals related to the physiological condition of an organism (such as a human body). Among them, the chemical signal may be a chemical signal generated by a chemical reaction with the modification layer material. For example, during the use of the medical device, when a specific biomarker in the blood vessel contacts the modification layer with a biological signal recognition function modified on the surface of the electrode 21, a chemical reaction occurs between the two, and the chemical signal change generated by the chemical reaction will be converted into a readable electrical signal through the electrode 21 and transmitted to the external circuit. The physical signal may be at least one of temperature, blood flow velocity, and blood pressure. For example, during the use of the medical device, when the above physical signals in the blood vessel change, the change will cause a responsive change in the physical properties of the modification layer on the surface of the electrode 21, and then the change will be converted into a readable electrical signal through the electrode 21 and transmitted to the external circuit.
[0080] The specific material of the modification layer is not limited as long as it can realize the above biological signal recognition function, for example, it can be one or more of enzymes, redox mediators, nanomaterials, antibodies, biotin, nucleic acid aptamers, polymers, ion carriers, and piezoelectric materials.
[0081] The enzyme includes but is not limited to at least one of oxidoreductase, transferase, hydrolase, lyase, ligase and isomerase.
[0082] Oxidoreductases include, but are not limited to, glucose oxidase, glutamate oxidase, alcohol oxidase, lactate oxidase, amino acid oxidase, cholesterol oxidase, choline oxidase, nicotinamide adenine dinucleotide phosphate oxidase, oxalate oxidase, cytochrome oxidase, bilirubin oxidase, serotoninase, galactose oxidase, glucose dehydrogenase, lactate dehydrogenase, alcohol dehydrogenase, aldehyde dehydrogenase, glutamate dehydrogenase, pyruvate dehydrogenase, sorbitol dehydrogenase, formate dehydrogenase, cellobiose dehydrogenase, amino acid dehydrogenase, succinate dehydrogenase, catalase, horseradish peroxidase, lactoperoxidase, glutathione peroxidase At least one of enzymes, ascorbate peroxidase, soybean peroxidase, cytochrome peroxidase, thyroid peroxidase, myeloperoxidase, superoxide dismutase, haloperoxidase, thiol peroxidase, 5α reductase, 5β reductase, aldehyde reductase, aldose reductase, hydroxymethylglutaryl coenzyme A reductase, methemoglobin reductase, ribonucleotide reductase, nitroreductase, thioredoxin reductase, dihydrofolate reductase, disulfide reductase, sulfite reductase, cytochrome reductase, imine reductase, fumarate reductase, carboxylic acid reductase, and dimethyl sulfoxide reductase.
[0083] The transferase includes, but is not limited to, at least one of glutathione transferase, acetyl transferase, methyl transferase, transketolase, transaldolase, glycosyl transferase, transketolase, amino acid transferase, and acyl transferase.
[0084] The hydrolase includes, but is not limited to, at least one of lipase, phosphohydrolase, glycoside hydrolase, acetylhydrolase, nucleotide hydrolase, helicase, peptide hydrolase, urease, and creatinine deiminase.
[0085] The lyase includes, but is not limited to, at least one of a decarboxylase, a dehydrogenase, a dehalogenase, an aspartate ammonia lyase, and a cysteine desulfurase.
[0086] The ligase includes, but is not limited to, at least one of tRNA synthetase, succinyl coenzyme A synthetase, amino acid ligase, DNA ligase, RNA ligase, and carboxylase.
[0087] Isomerases include, but are not limited to, at least one of racemase, epimerase, and mutase.
[0088] Nanomaterials include, but are not limited to, one or more of metal nanomaterials, nanoceramics, nanoglass, and nanopolymer materials.
[0089] The antibodies include, but are not limited to, one or more of C-reactive protein antibody, thyrotropin antibody, bilirubin antibody, albumin antibody, carcinoembryonic antigen antibody, alpha-fetoprotein antibody, prostate-specific antigen antibody, cancer antigen 125 antibody, and cortisol antibody.
[0090] The nucleic acid aptamer is selected from at least one of a DNA type oligonucleotide chain and an RNA type oligonucleotide chain.
[0091] The polymer is selected from one or more of polyaniline, polypyrrole, polyacetylene, polycarbazole, polythiophene, polyphenylene methylene, poly(3,4-ethylenedioxythiophene), polystyrene sulfonic acid, chitin, chitosan, polyvinyl chloride, polyvinyl butyral, and Nafion.
[0092] The ion carrier is selected from one or more of potassium ion, sodium ion, calcium ion, magnesium ion, iron ion, zinc ion, manganese ion, copper ion, molybdenum ion, cobalt ion, cobalt ion, chromium ion, chloride ion, sulfate ion, and phosphate ion.
[0093] The piezoelectric material is selected from at least one of single crystal piezoelectric ceramics, polycrystalline piezoelectric ceramics, piezoelectric polymers, and polymer-piezoelectric ceramic composites.
[0094] Specifically, among the above modification layer materials, the mechanism of action of some modification layer materials is as follows: when the vascular interventional diagnosis and treatment device is implanted in the blood vessel and used, if the modification layer detects the change of the corresponding biological signal edge, the modification layer material will undergo a corresponding chemical reaction, and electrons will be generated or consumed during the chemical reaction. The change in the number of electrons will be conducted through the electrode under the modification layer under the signal excitation of the external circuit and generate an electrical signal, which is finally transmitted to the external circuit to form a readable signal. Among them, the enzyme and the redox mediator mainly realize the above mechanism by coordination, and the nanomaterial alone or in coordination with the redox mediator can also realize the above mechanism. For example, if glucose oxidase is used as the modification layer material, but glucose molecules appear in the blood vessel, glucose oxidase will specifically react with glucose, and the electrons generated by the reaction will be transferred to the oxygen in the blood and generate hydrogen peroxide on the electrode surface. Hydrogen peroxide will react chemically under the excitation of the appropriate external circuit voltage and generate electrons. The electrons will flow from the electrode into the circuit under the drive of the electric field force and generate a readable current signal in the external circuit. The magnitude of the current signal is related to the glucose concentration in the blood vessel, thus, it can be used to judge the glucose concentration in the blood vessel.
[0095] The mechanism of action of some modification layer materials is as follows: when the vascular interventional diagnosis and treatment device is implanted in the blood vessel and used, if the modification layer detects changes in the biological signals in the blood vessel, the modification layer material will undergo corresponding chemical changes. After the chemical reaction, the impedance properties of the modification layer will change. The change in the impedance properties can be detected by the electrode under the modification layer under the signal excitation of the external circuit and generate an impedance signal. The impedance signal will eventually be transmitted to the external circuit to form a readable signal. Among them, nanomaterials, antibodies, biotin, nucleic acid aptamers, and polymers can all achieve the above mechanism alone or in combination with each other. For example, if cortisol antibodies are used as modification layer materials, when cortisol molecules appear in the blood vessels, the cortisol molecules will specifically chemically bind to the cortisol antibodies, which will cause the impedance of the electrode surface to increase. The impedance signal change can be read in the external circuit. The change in the impedance signal is related to the concentration of cortisol molecules in the blood vessels, so it can be used to judge the cortisol concentration in the blood vessels.
[0096] The electromagnetic shielding component 40 is configured to reduce or block the interference of external electromagnetic signals on the electrical signals transmitted by the electrical signal transmission component. Specifically, the electromagnetic shielding component 40 can be set on at least one side of the electrical signal transmission component 20, and the setting method can be configured according to actual needs (including the detection needs of the vascular interventional medical device and the setting position of the electrical signal transmission component 20). For example, if the electrical signal transmission component 20 is arranged on the inner side of the main frame 10, the electromagnetic shielding component 40 can be arranged between the electrical signal transmission component 20 and the main frame 10, and then the electromagnetic shielding component 40 is located on the outside of the electrical signal transmission component 20, which can reduce the interference of external electromagnetic signals to a certain extent; if the electrical signal transmission component 20 is arranged on the outside of the main frame 10, the electromagnetic shielding component 40 can be arranged on the side of the electrical signal transmission component 20 away from the main frame 10, and the electromagnetic shielding component 40 covers the wire 22 and exposes at least part of the electrode 21, and then the electromagnetic shielding component 40 is also located on the outside of the electrical signal transmission component 20, which can reduce the interference of external electromagnetic signals to a certain extent; in some embodiments, the above-mentioned electromagnetic shielding component 40 arranged between the electrical signal transmission component 20 and the main frame 10, and arranged on the side of the electrical signal transmission component 20 away from the main frame 10, covering the wire 22 and exposing at least part of the electrode 21, can also be used to cooperate, so as to improve the electromagnetic shielding effect by arranging electromagnetic shielding components 40 on both sides of the electrical signal transmission component 20.
[0097] In this embodiment, the electromagnetic shielding component 40 is configured to be disposed around the electrical signal transmission component 20 and expose at least a portion of the electrode 21. Figures 4-5 and Figure 8 , Fig.12As shown, in this embodiment, the battery shielding component 40 includes a first electromagnetic shielding component 41 and a second electromagnetic shielding component 42. The first electromagnetic shielding component 41 is arranged between the electrical signal transmission component 20 and the main frame 10, and the second electromagnetic shielding component 42 is arranged on the electrical signal transmission component 20 on a side away from the main frame 10, covering the wire 22 and exposing at least part of the electrode 21; the second electromagnetic shielding component 42 has a conductive connecting portion 43, the second electromagnetic shielding layer 42 is connected to the first electromagnetic shielding component 41 through the conductive connecting portion 43, and the conductive connecting portion 43 is evenly arranged on the second electromagnetic shielding component 42 in the circumferential direction corresponding to the electrical signal transmission component 20 ( Fig.12 Only a part is shown in the figure), and then the first electromagnetic shielding component 41, the second electromagnetic shielding component 42 and the conductive connection part 43 therebetween are arranged around the electrical signal transmission component 20. By surrounding the electrical signal transmission component 20, all-round protection can be achieved, effectively blocking the interference of external electromagnetic signals on the electrical signals transmitted by the electrical signal transmission component 20.
[0098] In some embodiments, the electromagnetic shielding member 40 is generally a conductive electromagnetic shielding member. Based on its conductivity, when it is combined with the electrical signal transmission component 20, it is necessary to control the electrical insulation between it and the electrical signal transmission component 20, and then an insulating layer 60 can be set between the electromagnetic shielding member 40 and the electrical signal transmission component 20 to electrically insulate and separate the electromagnetic shielding member 40 and the electrical signal transmission component 20. Of course, in some embodiments, other insulating connecting supports (such as insulating rod support rods, etc.) can be used to insulate and separate the electromagnetic shielding member 40 and the electrical signal transmission component 20. The electromagnetic shielding member 40 can be specifically set as any one of a metal shielding layer, a carbon nanotube shielding layer, a ferrite shielding layer, and a graphene shielding layer. The material of the metal shielding layer can be at least one of platinum and gold. The metal shielding layer can be made by at least one of sputtering, evaporation, and chemical vapor deposition. The material of the insulating layer 60 can be at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
[0099] In this embodiment, the first electromagnetic shielding member 41 and the second electromagnetic shielding member 42 are metal platinum shielding layers, and the conductive connecting portion 43 is made of the same material as the second electromagnetic shielding member 42; an insulating layer 60 made of polyimide is provided between the electromagnetic shielding member 40 and the electrical signal transmission component 20, as shown in FIG. Figures 4-5 and Fig. 9 , Fig.11As shown, the insulating layer 60 includes a first insulating layer 61 and a second insulating layer 62. The first insulating layer 61 is arranged between the first electromagnetic shielding component 41 and the electrical signal transmission component 20, and the second insulating layer 62 is arranged between the second electromagnetic shielding component 42 and the electrical signal transmission component 20. Through holes 63 are provided on the first insulating layer 61 and the second insulating layer 62 corresponding to the conductive connecting part 43 on the second electromagnetic shielding component 42. The conductive connecting part 43 on the second electromagnetic shielding component 42 is connected to the first electromagnetic shielding component 41 through the through holes 63.
[0100] In addition, in some embodiments, the electromagnetic shielding component 40 may also be configured to include an insulating layer and a conductive layer, wherein the insulating layer is arranged in contact with the electrical signal transmission component 20, and the conductive layer is arranged on the surface of the insulating layer away from the electrical signal transmission component 20, wherein electromagnetic shielding is mainly achieved through the conductive layer, and the insulating layer is used to achieve electrical insulation between the conductive layer and the electrical signal transmission component 20, and can play a connecting support role between the conductive layer and the electrical signal transmission component 20. The conductive layer is selected from any one of a metal layer, a carbon nanotube layer, a ferrite layer, and a graphene layer, and the material of the insulating layer can be at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
[0101] In order to ensure that the electromagnetic shielding component 40 effectively prevents interference with the signal transmitted by the electrical signal transmission component 20, the outer contour dimension of the electromagnetic shielding component 40 along the center direction of the main frame 10 is generally designed to be greater than or equal to the dimension of the corresponding electrical signal transmission component 20, and the corresponding setting position area of the electrical signal transmission component 20 on the main frame 10 can be regarded as constituting an assembly part of the electrical signal transmission component, and the electromagnetic shielding component 40 protects the electrical signal transmission component 20. Furthermore, in order to improve the stability of the structural setting, it can be designed that along the center direction of the main frame 10, the outer contour dimension of the electrical signal transmission component assembly part is equal to or greater than the outer contour dimension of the corresponding area on the electromagnetic shielding component 40. Specifically, the electrical signal transmission component assembly part includes an electrode assembly part and a wire assembly part. The electrode assembly part is composed of the corresponding setting position area of the electrode 21 in the electrical signal transmission component 20 on the main frame 10, and the wire assembly part is composed of the corresponding setting position area of the wire 22 in the electrical signal transmission component 20 on the main frame 10. It can be designed that along the center direction of the main frame 10, the outer contour dimension on the electrode assembly part is equal to or greater than the outer contour dimension of the corresponding area on the electromagnetic shielding component 40, and the outer contour dimension of the wire assembly part is equal to or greater than the outer contour dimension of the corresponding area on the electromagnetic shielding component 40. Further, the outer contour shape of the assembly part of the electric signal transmission component on the main frame 10 can be designed to be the same as the outer contour shape of the corresponding area on the electromagnetic shielding component 40, and the outer contour size of the assembly part of the electric signal transmission component is equal to or slightly larger than the outer contour size of the corresponding area on the electromagnetic shielding component 40; or, the outer contour shape of the assembly part of the electric signal transmission component on the main frame 10 can be designed to be different from the outer contour shape of the corresponding area on the electromagnetic shielding component 40, and the outer contour size of the assembly part of the electric signal transmission component on the main frame 10 is larger than the outer contour size of the corresponding area on the electromagnetic shielding component 40, that is, along the radial direction of the main frame 10, the outer contour of the area corresponding to the setting position of the electric signal transmission component 20 on the main frame 10 is larger than the outer contour of the corresponding area on the electromagnetic shielding component 40. Through the above structural design, the main frame 10 can fully support the electric signal transmission component 20 and the electromagnetic shielding component 40, further improving the stability of the structure.
[0102] In some embodiments, an electrical signal transmission component assembly groove may be provided on the electrical signal transmission component assembly portion of the main frame 10, and the electrical signal transmission component 20 may be assembled in the electrical signal transmission component assembly groove. In some embodiments in which an electromagnetic shielding component 40 is provided between the electrical signal transmission component 20 and the main frame 10, the electrical signal transmission component 20 is assembled in the electrical signal transmission component assembly groove, and an electromagnetic shielding component 40 is also provided between the electrical signal transmission component 20 and the main frame 10. Through this structural setting, the electrical signal transmission component 20 is installed in the electrical signal transmission component assembly groove, which can reduce the thickness of the structure on the one hand, and on the other hand, the side wall of the electrical signal transmission component assembly groove can limit the electrical signal transmission component 20 to avoid displacement of the electrical signal transmission component 20 during use, thereby further improving the structural stability.
[0103] like Figure 1 , Figure 4 , Figure 5 and Fig.13 As shown, the vascular interventional medical device of this embodiment also includes an insulating packaging layer 30, which is arranged on the outermost layer of the main frame 10 on the side where the electrical signal transmission component 20 is provided, and exposes at least part of the electrode 21, thereby playing the role of insulation, packaging and protection. Specifically, a through hole can be opened on the insulating packaging layer 30 corresponding to the position where the electrode 21 is set to expose at least part of the electrode 21. The material of the insulating packaging layer 30 can be selected from at least one of polyimide (PI), polydimethylsiloxane (PDMS), poly(p-phenylene benzobisoxazole) (PBO), and SU8.
[0104] In some embodiments, the insulating packaging layer 30 may also be eliminated. For example, when an electromagnetic shielding member 40 is provided on the side of the electrical signal transmission component 20 away from the main frame 10, the electromagnetic shielding member 40 located on the side of the electrical signal transmission component 20 away from the main frame 10 can play a certain packaging and protection role for the electrical signal transmission component 20, and thus the insulating packaging layer 30 may be eliminated. The situation where the electromagnetic shielding member 40 is provided on the side of the electrical signal transmission component 20 away from the main frame 10 includes: the electromagnetic shielding member 40 is provided on the side of the electrical signal transmission component 20 away from the main frame 10, covering the wire 22 and exposing at least part of the electrode 21; or, the electromagnetic shielding member 40 is provided between the electrical signal transmission component 20 and the main frame 10, and on the side of the electrical signal transmission component 20 away from the main frame 10, covering the wire 22 and exposing at least part of the electrode 21; or the electromagnetic shielding member 40 is provided around the electrical signal transmission component 20, and exposing at least part of the electrode 21.
[0105] In addition, in some embodiments, in order to improve the safety of the vascular interventional medical device implantation process, the vascular interventional medical device may also include a buffer protection component, which is configured to reduce the risk of puncturing a blood vessel during the vascular interventional medical device implantation process. Specifically, the buffer protection component may be disposed at the implantation front end of the vascular interventional medical device. In addition, the buffer protection component may be designed to have an arc-shaped buffer surface at the front end of the deployment intervention. For example, the buffer protection component may be designed to be spherical, semi-spherical, ellipsoidal, semi-ellipsoidal, etc. By deploying the arc-shaped buffer surface design of the front end of the intervention intervention of the buffer protection component, it can play an effective buffering and protective role in the process of deploying the implanted blood vessel, thereby reducing the risk of puncturing the blood vessel.
[0106] In some embodiments, when the above vascular interventional medical device is deployed, it can be used in conjunction with an external delivery component to deploy the vascular interventional diagnostic and treatment device to a target site in a blood vessel. Of course, in some embodiments, the vascular interventional diagnostic and treatment device can also be designed to include a delivery component, which is configured to deploy and implant the vascular interventional diagnostic and treatment device into a blood vessel. The delivery component can be a delivery shaft, which can be configured to pass through the main frame 10, and one end of which is connected to the deployment front end of the main frame 10 or a buffer protection component provided at the deployment front end of the main frame 10.
[0107] The above vascular interventional medical device can be applied to a vascular interventional medical system, and the present invention further proposes a vascular interventional medical system, which includes any of the above vascular interventional medical devices. Specifically, one end of the wire 22 of the electrical signal transmission component 20 in the vascular interventional medical device is connected to the electrode 21 on the electrical signal transmission component 20, and the wire 22 extends along the side wall of the main frame 10, and is configured to be led out and electrically connected to an external device. The external device can be equipped as needed. For example, in some embodiments, the external device is only used to receive the signal data detected by the electrode and transmitted through the wire; or, in some embodiments, in addition to receiving the signal data detected by the electrode and transmitted through the wire, the external device can also process it to obtain the target signal data; or, in some embodiments, in addition to receiving and processing the signal data transmitted by the vascular interventional diagnosis and treatment device, the external device can further generate a control signal and transmit the control signal to other devices; or, the external device can be a driving power supply to apply electrical stimulation to the vascular wall cells through the wire and the electrode; in addition, other external devices can be configured as needed.
[0108] In addition, the above-mentioned vascular interventional medical systems can also be used to construct in vitro cultured cell constructs, electrical signal collection cell constructs, and electrical stimulation cell constructs. Furthermore, the present application also proposes the use of more than one vascular interventional medical system in constructing in vitro cultured cell constructs, electrical signal collection cell constructs, or electrical stimulation cell constructs.
[0109] The above-mentioned embodiments only express several implementation methods of the present invention, and the description thereof is relatively specific and detailed, but it cannot be understood as limiting the scope of the present invention. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A vascular interventional medical device, characterized in that: include: A main frame, wherein the main frame is an elastic support frame, and the side wall of the main frame is a mesh structure; An electrical signal transmission component, the electrical signal transmission component is arranged on the main frame, and comprises an electrode and a wire, the wire is electrically connected to the electrode, and the electrode is arranged at the intersection of the mesh structure on the main frame; An electromagnetic shielding member, wherein the electromagnetic shielding member is configured to reduce or block interference of external electromagnetic signals on the electrical signal transmitted by the electrical signal transmission component; Among them, the electromagnetic shielding component includes a first electromagnetic shielding component and a second electromagnetic shielding component, the first electromagnetic shielding component is arranged between the electrical signal transmission component and the main frame, and the second electromagnetic shielding component is arranged on the side of the electrical signal transmission component away from the main frame, covering the wire and exposing at least part of the electrode; the second electromagnetic shielding component has a conductive connecting part, the second electromagnetic shielding component is connected to the first electromagnetic shielding component through the conductive connecting part, and the conductive connecting part is evenly distributed on the second electromagnetic shielding component in the circumferential direction corresponding to the electrical signal transmission component; the first electromagnetic shielding component and the second electromagnetic shielding component both have a mesh structure.
2. The vascular interventional medical device according to claim 1, characterized in that: An insulating layer is provided between the electromagnetic shielding component and the electrical signal transmission component.
3. The vascular interventional medical device according to claim 2, characterized in that: The electromagnetic shielding component is selected from any one of a metal shielding layer, a carbon nanotube shielding layer, a ferrite shielding layer, and a graphene shielding layer.
4. The vascular interventional medical device according to claim 3, characterized in that: The material of the metal shielding layer is selected from at least one of platinum and gold.
5. The vascular interventional medical device according to claim 2, characterized in that: The material of the insulating layer is selected from at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
6. The vascular interventional medical device according to claim 1, characterized in that: The electrical signal transmission component is configured by a conductive material layer.
7. The vascular interventional medical device according to claim 6, characterized in that: The electrode and the lead are in an integrated structure.
8. The vascular interventional medical device according to claim 6, characterized in that: The conductive material layer is a metal material layer, a non-metal conductive material layer, or a composite layer of a non-metal conductive material layer and a metal material layer.
9. The vascular interventional medical device according to claim 6, characterized in that: The conductive material layer includes a non-precious metal conductive base layer and a precious metal protective layer. The non-precious metal conductive base layer is arranged on the surface of the main frame, and the precious metal protective layer covers the non-precious metal conductive base layer. The material of the precious metal protective layer is selected from at least one of platinum and gold.
10. The vascular interventional medical device according to claim 6, characterized in that: The thickness of the conductive material layer is less than 5 μm.
11. The vascular interventional medical device according to claim 1, characterized in that: The main frame is configured to be contractible and expandable along a central axis.
12. The vascular interventional medical device according to claim 1, characterized in that: There are two or more electrodes.
13. The vascular interventional medical device according to claim 1, characterized in that: The electrodes are evenly arranged along the axial direction of the main frame.
14. The vascular interventional medical device according to claim 1, characterized in that: The surface of the electrode is provided with a modification layer, which has a biological signal recognition function for identifying and detecting changes in biological signals within blood vessels, and converting the changes in the biological signals into readable electrical signals through the electrode and transmitting them to an external circuit; the biological signals include chemical signals and / or physical signals related to the physiological condition of the organism.
15. The vascular interventional medical device according to claim 14, characterized in that: The material of the modification layer is selected from at least one of enzymes, redox mediators, nanomaterials, antibodies, biotin, nucleic acid aptamers, polymers, ion carriers, and piezoelectric materials.
16. The vascular interventional medical device according to claim 15, characterized in that: The enzyme is selected from at least one of oxidoreductase, transferase, hydrolase, lyase, ligase and isomerase.
17. The vascular interventional medical device according to claim 16, characterized in that: The oxidoreductase is selected from the group consisting of glucose oxidase, glutamate oxidase, alcohol oxidase, lactate oxidase, amino acid oxidase, cholesterol oxidase, choline oxidase, nicotinamide adenine dinucleotide phosphate oxidase, oxalate oxidase, cytochrome oxidase, bilirubin oxidase, serotoninase, galactose oxidase, glucose dehydrogenase, lactate dehydrogenase, alcohol dehydrogenase, aldehyde dehydrogenase, glutamate dehydrogenase, pyruvate dehydrogenase, sorbitol dehydrogenase, formate dehydrogenase, cellobiose dehydrogenase, amino acid dehydrogenase, succinate dehydrogenase, catalase, horseradish peroxidase, lactoperoxidase, glutathione peroxidase , ascorbate peroxidase, soybean peroxidase, cytochrome peroxidase, thyroid peroxidase, myeloperoxidase, superoxide dismutase, haloperoxidase, thiol peroxidase, 5α reductase, 5β reductase, aldehyde reductase, aldose reductase, hydroxymethylglutaryl coenzyme A reductase, methemoglobin reductase, ribonucleotide reductase, nitroreductase, thioredoxin reductase, dihydrofolate reductase, disulfide reductase, sulfite reductase, cytochrome reductase, imine reductase, fumarate reductase, carboxylic acid reductase, dimethyl sulfoxide reductase.
18. The vascular interventional medical device according to claim 16, characterized in that: The transferase is selected from at least one of glutathione transferase, acetyl transferase, methyl transferase, transketolase, transaldolase, glycosyl transferase, transketolase, amino acid transferase and acyl transferase.
19. The vascular interventional medical device according to claim 16, characterized in that: The hydrolase is selected from at least one of lipase, phosphohydrolase, glycoside hydrolase, acetyl hydrolase, nucleotide hydrolase, helicase, peptide hydrolase, urease and creatinine deiminase.
20. The vascular interventional medical device according to claim 16, characterized in that: The lyase is selected from at least one of decarboxylase, dehydrogenase, dehalogenase, aspartate ammonia lyase and cysteine desulfurase.
21. The vascular interventional medical device according to claim 16, characterized in that: The ligase is selected from at least one of tRNA synthetase, succinyl coenzyme A synthetase, amino acid ligase, DNA ligase, RNA ligase and carboxylase.
22. The vascular interventional medical device according to claim 16, characterized in that: The isomerase is selected from at least one of a racemase, an epimerase and a mutase.
23. The vascular interventional medical device according to claim 15, characterized in that: The nanomaterial is selected from at least one of metal nanomaterials, nanoceramics, nanoglass, and nanopolymer materials.
24. The vascular interventional medical device according to claim 15, characterized in that: The antibody is selected from at least one of C-reactive protein antibody, thyrotropin antibody, bilirubin antibody, albumin antibody, carcinoembryonic antigen antibody, alpha-fetoprotein antibody, prostate-specific antigen antibody, cancer antigen 125 antibody, and cortisol antibody.
25. The vascular interventional medical device according to claim 15, characterized in that: The nucleic acid aptamer is selected from at least one of a DNA type oligonucleotide chain and an RNA type oligonucleotide chain.
26. The vascular interventional medical device according to claim 15, characterized in that: The polymer is selected from at least one of polyaniline, polypyrrole, polyacetylene, polycarbazole, polythiophene, polyphenylene methylene, poly(3,4-ethylenedioxythiophene), polystyrene sulfonic acid, chitin, chitosan, polyvinyl chloride, polyvinyl butyral, and Nafion.
27. The vascular interventional medical device according to claim 15, characterized in that: The ion carrier is selected from at least one of potassium ion, sodium ion, calcium ion, magnesium ion, iron ion, zinc ion, manganese ion, copper ion, molybdenum ion, cobalt ion, cobalt ion, chromium ion, chloride ion, sulfate ion and phosphate ion.
28. The vascular interventional medical device according to claim 15, characterized in that: The piezoelectric material is selected from at least one of single crystal piezoelectric ceramics, polycrystalline piezoelectric ceramics, piezoelectric polymers, and polymer-piezoelectric ceramic composites.
29. The vascular interventional medical device according to claim 1, characterized in that: The area on the main frame corresponding to the setting position of the electrical signal transmission component constitutes an electrical signal transmission component assembly part. Along the direction toward the center of the main frame, the outer contour size of the electrical signal transmission component assembly part is equal to or greater than the outer contour size of the corresponding area of the electromagnetic shielding component.
30. The vascular intervention medical device according to claim 29, characterized in that: The electrical signal transmission component assembly portion is provided with an electrical signal transmission component assembly groove, and the electrical signal transmission component is assembled in the electrical signal transmission component assembly groove.
31. The vascular interventional medical device according to any one of claims 1 to 30, characterized in that: The material of the main frame is selected from degradable polymer materials; Alternatively, the material of the main frame is selected from at least one of shape memory alloy and iron, and a dielectric layer is provided on the surface of the main frame, and the dielectric layer is arranged toward a side of the electrical signal transmission component.
32. The vascular interventional medical device according to claim 31, characterized in that: The material of the dielectric layer is selected from at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
33. The vascular interventional medical device according to claim 31, characterized in that: The shape memory alloy is selected from at least one of Nitinol alloy, cobalt-chromium alloy and magnesium alloy.
34. The vascular interventional medical device according to any one of claims 1 to 30, characterized in that: It also includes an insulating packaging layer, which is configured as the outermost layer on the side of the main frame where the electrical signal transmission component is provided, and exposes at least part of the electrode.
35. The vascular interventional medical device according to claim 34, characterized in that: The material of the insulating packaging layer is selected from at least one of polyimide, polydimethylsiloxane, poly(p-phenylene benzobisoxazole), and SU8.
36. The vascular interventional medical device according to claim 34, characterized in that: It also includes a buffer protection component, which is arranged at the implantation front end of the vascular interventional medical device and is configured to reduce the risk of puncturing a blood vessel during the implantation process of the vascular interventional medical device.
37. The vascular interventional medical device according to claim 34, characterized in that: Also included is a delivery component configured to deploy and implant the vascular intervention medical device into a blood vessel.
38. A vascular interventional medical system, characterized in that: A vascular interventional medical device comprising any one of claims 1 to 37.
39. Use of the vascular interventional medical system of claim 38 in constructing an in vitro cultured cell construct, an electrical signal acquisition cell construct or an electrical stimulation cell construct.
Citation Information
Patent Citations
Endovascular device for sensing and or stimulating tissue
CN111132726A
Implantable medical device with cavitation features
CN112867456A
Intravascular stent electrode array, preparation method thereof and electrical stimulation system
CN114887220A
Bioelectrode, and interlayer electric connection structure
JP2013132440A
Lead or lead extension having a conductive body and conductive body contact
US20080269863A1
